Crinetics Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CRNX Nasdaq 2836 www.crinetics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Crinetics Pharmaceuticals, Inc.

What Do Analysts Say About Crinetics Pharmaceuticals (CRNX)? - May 29th, 2026 4:31 am
[Latest] Global Bioprocess Automation Software Market Size/Share Worth USD 6.19 Billion by 2035 at a 14 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - May 25th, 2026 10:30 pm
Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026 - May 22nd, 2026 2:05 pm
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy? - May 18th, 2026 12:10 pm
Industry Analysts Just Upgraded Their Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Revenue Forecasts By 11% - May 13th, 2026 6:11 am
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates - May 11th, 2026 8:18 am
Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Recent Share Price Momentum - May 9th, 2026 1:09 pm
Crinetics (CRNX) Q1 2026 Earnings Transcript - May 8th, 2026 8:37 am
Crinetics Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - May 8th, 2026 6:30 am
Crinetics Pharmaceuticals Q1 Earnings Call Highlights - May 7th, 2026 6:38 pm
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Beats Revenue Estimates - May 7th, 2026 3:55 pm
Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update - May 7th, 2026 2:05 pm
The Bull Case For Crinetics Pharmaceuticals (CRNX) Could Change Following EU Nod For Oral Acromegaly Drug PALSONIFY - May 4th, 2026 10:11 am
Will Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should Know - May 4th, 2026 8:00 am
Crinetics Pharmaceuticals (CRNX): Billionaire Tom Steyer Likes This Pharma Stock - May 2nd, 2026 8:50 am
Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for - Apr 30th, 2026 8:00 am
Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why - Apr 29th, 2026 7:17 am
Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults - Apr 27th, 2026 3:13 pm
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates - Apr 22nd, 2026 5:20 am
Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer - Apr 15th, 2026 12:00 pm